Surveillance et intervention de santé

Bellera CA, Pulido M, Gourgou S, Collette L, Doussau A, Kramar A, Dabakuyo TS, Ouali M, Auperin A, Filleron T, Fortpied C, Le Tourneau C, Paoletti X, Mauer M, Mathoulin-Pelissier S, Bonnetain F. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials. Eur J Cancer 2012;49(4):769-781

Bui-Nguyen B, Ray-Coquard I, Chevreau C, Penel N, Bay JO, Coindre JM, Cupissol D, Italiano A, Bonichon F, Lotz JP, Thyss A, Jimenez M, Mathoulin-Pélissier S, Blay JY, GSF-GETO French Sarcoma Group. High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial. Ann Oncol 2012;23(3):777-784

Coureau G, Baldi I, Saves M, Jaffre A, Barat C, Gruber A, Loiseau H, Kostrzewa A, Servas V, Salamon R, Gilleron V. Evaluation des performances du PMSI pour l’identification des tumeurs incidentes du système nerveux central par rapport à un registre spécialisé en Gironde, France, en 2004. Rev Epidemiol Sante Publique 2012;60(4):295-304

Delva F, Soubeyran P, Rainfray M, Mathoulin-Pelissier S. Referral of elderly cancer patients to specialists: Action proposals for general practitioners. Cancer Treat Rev 2012;38(7):935-941

Doussau A, Asselain B, Le Deley MC, Geoerger B, Doz F, Vassal G, Paoletti X. Dose-finding designs in pediatric phase I clinical trials: Comparison by simulations in a realistic timeline framework. Contemp Clin Trials 2012;33(4):657-665

Durrieu J, Doussau A, Rieger A, Terrebonne E, Bouabdallah K, Zwolakowski MD, Maget B, Dauba J, Mariette C, Trager S, Perie JL, Robert B, Regueme SC, Bourdel-Marchasson I. Design of a physical activity program to prevent functional decline in onco-geriatric patients (capadoge): a randomized multicenter trial. J Frail Aging 2012;1(3):138-143

Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, Fonck M, Becouarn Y, Lalet C, Puildo M, Mathoulin-Pelissier S. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg 2012;99(4):558-565

Mathoulin-Pelissier S, Becouarn Y, Belleannee G, Pinon E, Jaffre A, Coureau G, Auby D, Renaud-Salis JL, Rullier E. Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospitalrelated factors. BMC Cancer 2012;12(1):297

Mazroui Y, Mathoulin-Pelissier S, Soubeyran P, Rondeau V. General joint frailty model for recurrent event data with a dependent terminal event: Application to follicular lymphoma data. Stat Med 2012;31(11-12):1162-1176

Monnereau A, Troussard X, Belot A, Guizard AV, Woronoff AS, Bara S, Lapotre-Ledoux B, Iwaz J, Tretarre B, Maynadie M, the French Network of Cancer Registries. Unbiased estimates of long-term net survival of haematological malignancy patients detailed by major subtypes in France. Int J Cancer 2012;132(10):2378-2387

 Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, Imbert Y, Cany L, Vogt L, Dauba J, Andriamampionona F, Houede N, Floquet A, Chomy F, Brouste V, Ravaud A, Bellera C, Rainfray M. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012;30(15):1829-1834

Ray-Coquard I, Montesco MC, Coindre JM, Dei Tos AP, Lurkin A, Ranchere-Vince D, Vecchiato A, Decouvelaere AV, Mathoulin-Pelissier S, Albert S, Cousin P, Cellier D, Toffolatti L, Rossi CR, Blay JY. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol 2012 23(9):2442-2449

Bellera C, Praud D, Petit-Moneger A, McKelvie-Sebileau P, Soubeyran P, Mathoulin-Pelissier S. Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin’s lymphoma: A systematic review. Cancer Treat Rev 2013;39(7):812-817

Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2013;23(8):2166-72

Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF, Jr., de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013;45(8):868-876

Boisserie-Lacroix M, Macgrogan G, Debled M, Ferron S, Asad-Syed M, McKelvie-Sebileau P, Mathoulin-Pelissier S, Brouste V, Hurtevent-Labrot G. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Oncologist 2013;18(7):802-811

Bullier E, Descat E, Bonichon F, Picat MQ, Bellera C, Evrard S, Cazeau AL. Diagnostic accuracy of (18) F-FDG PET/CT for the detection of peritoneal carcinomatosis of colorectal origins. J Cancer Res Ther 2013;1(1):46-53

Colombani F, Pereira E, Bettaieb J, Gobin L, Cowppli-Bony A, Hoppe S, Coureau G, Picat MQ, Salamon R, Monnereau A, Saves M. Intérêt des données du registre hospitalier (Enquête permanente cancer) d’un centre régional de lutte contre le cancer pour un registre de cancer en population. Rev Epidemiol Sante Publique 2013;61(1):1-9

Kamper-Jorgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE, Sanjose S, Chang ET, Zheng T, La Vecchia C, Serraino D, Monnereau A, Kane EV, Miligi L, Vineis P, Spinelli JJ, McLaughlin JR, Pahwa P, Dosman JA, Vornanen M, Foretova L, Maynadie M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Hjalgrim H. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol 2013;24(9):2245-2255

 Mathoulin-Pelissier S, Bellera C, Rainfray M, Soubeyran I. Screening methods for geriatric frailty [letter]. Lancet Oncol 2013;14:e1-e2

 Palussiere J, Henriques C, Mauriac L, Asad-Syed M, Valentin F, Brouste V, Mathoulin-Pelissier S, Tunon de Lara C, Debled M. Radiofrequency Ablation as a Substitute for Surgery in Elderly Patients with Nonresected Breast Cancer: Pilot Study with Long-term Outcomes. Radiology 2013;264(2):597-605

Rondeau V, Schaffner E, Corbiere F, Gonzalez JR, Mathoulin-Pelissier S. Cure frailty models for survival data: Application to recurrences for breast cancer and to hospital readmissions for colorectal cancer. Stat Methods Med Res 2013;22(3):243-260

Cocco P, Vermeulen R, Flore V, Nonne T, Campagna M, Purdue M, Blair A, Monnereau A, Orsi L, Clavel J, Becker N, de Sanjose S, Foretova L, Staines A, Maynadie M, Nieters A, Miligi L, t Mannetje A, Kricker A, Brennan P, Boffetta P, Lan Q, Rothman N. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled IinterLlymph analysis. Occup Environ Med 2013 70(11):795-802

Doussau A, Thiebaut R, Paoletti X. Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase I oncology clinical trials. Stat Med 2013 32(30):5430-5447

Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc JF, Ceccaldi J, Mertens C, Blanc-Bisson C, Imbert Y, Cany L, Vogt L, Dauba J, Houede N, Bellera CA, Floquet A, Fabry MN, Ravaud A, Chakiba C, Mathoulin-Pelissier S, Soubeyran P. Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. J Clin Oncol 2013 31(31):3877-3882

Mauguen A, Rachet B, Mathoulin-Pelissier S, Macgrogan G, Laurent A, Rondeau V. Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models. Stat Med 2013 32(30):5366-5380

Mazroui Y, Mathoulin-Pelissier S, Macgrogan G, Brouste V, Rondeau V. Multivariate frailty models for two types of recurrent events with a dependent terminal event: Application to breast cancer data. Biom J 2013 55(6):866-884

Monnereau A, Glaser SL, Schupp CW, Ekstrom Smedby K, de Sanjose S, Kane E, Melbye M, Foretva L, Maynadie M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Glimelius I, Clavel J, Hjalgrim H, Chang ET. Exposure to ultraviolet radiation and risk of Hodgkin lymphoma: a pooled analysis. Blood 2013 122(20):3492-3499

Trebouet A, Marchand T, Lemal R, Gyan E, Broussais-Guillaumot F, Guillermin Y, Monjanel H, Salles G, Le Gouill S, Godmer P, Fruchart C, Damaj G, Feugier P, Thieblemont C, Maynadie M, Monnereau A, Troussard X, Rossille D, Lamy T, Houot R. Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. Ann Oncol 2013 24(10):2612-2618

Floquet A, Doussau A, Brouste V, Cany L, Dutin JP, Mathoulin-Pélissier S. Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.Cancer Chemother Pharmacol 2014;73(1):61-8.

Mathoulin-Pelissier S, Chevreau C, Bellera C, Bauvin E, Saves M, Grosclaude P, Albert S, Goddard J, Le Guellec S, Delannes M, Bui BN, Mendiboure J, Stoeckle E, Coindre JM, Kantor G, Kind M, Cowppli-Bony A, Hoppe S, Italiano A. Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study. Ann Oncol 2014;25(1):225-31

 Grellety T, Petit-Moneger A, Diallo A, Mathoulin-Pelissier S, Italiano A. Quality of reporting of phase II trials: a focus on highly ranked oncology journals. Ann Oncol 2014;25(2):536-41.

Coureau G, Bouvier G, Lebailly P, Fabbro-Peray P, Gruber A, Leffondre K, Guillamo JS, Loiseau H, Mathoulin-Pélissier S, Salamon R, Baldi I. Mobile phone use and brain tumours in the CERENAT case-control study. Occup Environ Med. 2014 May 9. doi: 10.1136/oemed-2013-101754.

Leux C, Maynadié M, Troussard X, Cabrera Q, Herry A, Le Guyader-Peyrou S, Le Gouill S, Monnereau A. Mantle cell lymphoma epidemiology: a population-based study in France Ann Hematol. 2014 Apr 25.

Bellera CA, Penel N, Ouali M, Bonvalot S, Casalli PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin R, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijder S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. Guidelines for time-to-event endpoint definitions in sarcomas and gastro-intestinal stromal tumors (GIST) trials. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).Ann Oncol. 2014 Jul 28.